Description and Brand Names
Drug information provided by: Micromedex
US Brand Name
Lenvatinib is used to treat progressive, differentiated thyroid cancer that can no longer be treated with radioactive iodine and has already spread to different parts of the body. This medicine is used in combination with everolimus to treat advanced kidney cancer in patients who have received other treatments. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Lenvatinib is an antineoplastic (cancer) medicine.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: